{
    "2020-12-04": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Novo Nordisk files for US FDA regulatory approval of once-weekly semaglutide 2.4 mg for weight management",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "FDA",
                        "regulatory approval",
                        "semaglutide",
                        "weight management"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}